What is staphylococcal scalded skin syndrome in children? Staphylococcal scalded skin syndrome (SSSS) is a serious skin infection. The infection causes peeling skin over large parts of the body. It ...

BioAge valued at $758 mln in debut as investors bet on weight-loss drug frenzy September 26, 2024 Weight-loss drug developer BioAge raises $198 mln in U.S. IPO September 26, 2024 Obesity drug ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Trying to achieve healthier skin? Follow these quick tips from board-certified dermatologists to learn healthy skin habits. For even more recommendations on maintaining healthy skin, see the list ...

BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. BioAge’s lead ...

RICHMOND, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- BioAge Labs (Nasdaq: BIOA) (“BioAge”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic ...

RICHMOND, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- BioAge Labs (Nasdaq: BIOA) (“BioAge”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases ...

WASHINGTON - The Biden administration announced a new $20 billion loan to Ukraine which will be backed by the value of frozen Russian assets. The loan, known as the Extraordinary Revenue ...

Crafting a diligent and effective skin routine is not at all easy, and requires years of research and a long journey of trial and error that often comes with a hefty ...

Pictures of skin lesions can help you to identify changes in the skin that healthcare providers typically consider, including the color, size, texture, and location. These lesions differ from the ...

On Monday, Citi initiated coverage on BioAge Labs Inc (NASDAQ:BIOA) shares, giving the biotech company a Buy rating and setting a price target of $45.00. The firm highlighted BioAge's focus on ...

On Monday, Morgan Stanley (NYSE:MS) initiated coverage on BioAge Labs Inc (NASDAQ:BIOA), assigning the stock an Overweight rating and setting a price target of $40.00. The new rating reflects the ...